tiprankstipranks
Ikena Oncology (IKNA)
NASDAQ:IKNA
US Market

Ikena Oncology (IKNA) Technical Analysis

Compare
98 Followers

Technical Sentiment

Overall Consensus
Strong Sell
4Bullish
3Neutral
15Bearish
Technical Analysis Consensus
Neutral
4Bullish
3Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Ikena Oncology’s (IKNA) Moving Averages Convergence Divergence (MACD) indicator is -0.03, suggesting Ikena Oncology is a Sell.
Ikena Oncology’s (IKNA) 20-Day exponential moving average is 1.47, while Ikena Oncology’s (IKNA) share price is $1.39, making it a Sell.
Ikena Oncology’s (IKNA) 50-Day exponential moving average is 1.53, while Ikena Oncology’s (IKNA) share price is $1.39, making it a Sell.

Ikena Oncology (IKNA) Pivot Points

Feb 23, 2025, 04:04 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.42
1.44
1.44
1.46
1.46
1.48
1.48
Fibonacci
1.44
1.44
1.45
1.46
1.46
1.47
1.48
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ikena Oncology (IKNA) Moving Averages

Feb 23, 2025, 04:04 AM
Period
Simple
Exponential
MA5
1.45Sell
1.44Sell
MA10
1.46Sell
1.45Sell
MA20
1.47Sell
1.47Sell
MA50
1.54Sell
1.53Sell
MA100
1.62Sell
1.58Sell
MA200
1.63Sell
1.57Sell
Ikena Oncology’s (IKNA) 10-Day exponential moving average is 1.45, while Ikena Oncology’s (IKNA) share price is $1.39, making it a Sell.
Ikena Oncology’s (IKNA) 100-Day exponential moving average is 1.58, while Ikena Oncology’s (IKNA) share price is $1.39, making it a Sell.
Ikena Oncology’s (IKNA) stock price is $1.39 and Ikena Oncology’s (IKNA) 50-day simple moving average is 1.54, creating a Sell signal.
Ikena Oncology’s (IKNA) stock price is $1.39 and Ikena Oncology’s (IKNA) 100-day simple moving average is 1.62, creating a Sell signal.
Ikena Oncology’s (IKNA) stock price is $1.39 and Ikena Oncology’s (IKNA) 200-day simple moving average is 1.63, creating a Sell signal.

Ikena Oncology (IKNA) Technical Indicators

Feb 23, 2025, 04:04 AM
Name
Value
Implied Action
RSI (14)
36.14
Neutral
STOCH (9,6)
18.18
Buy
STOCHRSI (14)
20.56
Neutral
MACD (12,26)
-0.03
Sell
ADX (14)
16.85
Buy
Williams %R
-95.45
Buy
CCI (14)
-148.33
Buy
ATR (14)
0.07
-
Ultimate Oscillator
37.68
Neutral
ROC
-6.08
Sell
Ikena Oncology’s (IKNA) Relative Strength Index (RSI) is 36.14, creating a Neutral signal.
Ikena Oncology’s (IKNA) Trend Strength Indicator (ADX) is 16.85, creating a Buy signal.
Ikena Oncology’s (IKNA) Commodity Channel Index (CCI) is -148.33, creating a Buy signal.
Ikena Oncology’s (IKNA) Price Rate of Change (ROC) is -6.08, creating a Sell signal.

FAQ

Is IKNA a Buy, Hold, or Sell?
Based on IKNA’s technical indicators, IKNA is a Strong Sell.
    What is IKNA’s RSI (14)?
    IKNA’s RSI (14) is 36.14, which suggests IKNA is a Neutral.
      What is IKNA’s MACD?
      IKNA’s MACD is -0.03, which suggests IKNA is a Sell.
        What is IKNA’s 5-day moving average?
        IKNA’s 5-day moving average is 1.45, which suggests IKNA is a Sell.
          What is IKNA’s 20-day moving average?
          IKNA 20-day moving average is 1.47, which suggests IKNA is a Sell.
            What is IKNA’s 50-day moving average?
            IKNA’s 50-day moving average is 1.54, which suggests IKNA is a Sell.
              What is IKNA’s 200-day moving average?
              IKNA’s 200-day moving average is 1.63, which suggests IKNA is a Sell.
                What is IKNA’s Williams % R (14)?
                IKNA’s Williams % R (14) is -95.45, which suggests IKNA is a Buy.
                  What is IKNA’s CCI (14)?
                  IKNA’s CCI (14) is -148.33, which suggests IKNA is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis